Department of Uro Oncology and Robotic Surgery, HCG Cancer Center, Bengaluru, India.
J Robot Surg. 2024 Mar 4;18(1):106. doi: 10.1007/s11701-023-01758-w.
Robot-assisted surgery is developing as an acme of minimally invasive surgery, given its utmost dominance over laparoscopic surgery. The objective was to review the status of robotic surgery in urological practice with its advantages and disadvantages in current scenario. We conducted a literature search using MEDLINE and identified 72 articles which were relevant to urology. Single-port and various multiport robotic platforms like Da Vinci, Versius, Hugo RAS, Revo-I, Senhance, Mantra, Avatera, Hinotori, and MicroSurge are described with pros and cons. With a surge in different medical surgical robots purging into the market and a race to become the next standard of care in robotic surgery, it is only a matter of time when robotic surgery becomes financially comparable to laparoscopic surgeries.
机器人辅助手术作为微创外科的巅峰,因其对腹腔镜手术的绝对优势而不断发展。本研究旨在综述机器人手术在泌尿外科实践中的现状,探讨其当前的优缺点。我们使用 MEDLINE 进行文献检索,共确定了 72 篇与泌尿外科相关的文章。本文介绍了单端口和各种多端口机器人平台,如达芬奇、Versius、Hugo RAS、Revo-I、Senhance、Mantra、Avatera、Hinotori 和 MicroSurge,并讨论了它们的优缺点。随着各种医用手术机器人涌入市场,竞相成为机器人手术的下一个护理标准,机器人手术在经济上与腹腔镜手术相媲美的时代即将到来。